Research Compliance News and Resources
Latest News
To ensure that research policies reflect current procedures, objectives, and functions, policies are reviewed at least every 3 to 5 years or as needed depending on regulatory changes. Each policy follows a standard approval process including review by the Office of the Provost and the President's Office.
The most recently approved policies are as follows:
7.25 Use of Controlled Substances and Dangerous Drugs in Research
Find the detailed policy and implementation guidance at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-149.html
The National Institutes of Health (NIH) currently requires grants with $500,000 per year or more in direct costs to explain how and when data resulting from the grant will be disseminated. Beginning in 2023, the NIH will require all grant applications or renewals that generate scientific data to include a robust and detailed plan for data sharing and management during the entire funding period. This information will need to be provided in a data management and sharing plan (known as a DMSP).
The DMSP will be assessed by NIH program staff members, and the approved plan is considered a Term and Condition of the Notice of Award. Researchers must submit a DMSP as part of their funding application for all new and competing proposals/renewals that generate scientific data on or after January 25, 2023.
What you need to do:
- Know that help is available! The Research Compliance and Regulatory Affairs office is collaborating with the Emory Libraries and the Office of Information Technology to support faculty as they comply with this new policy. This newly appointed team is exploring and benchmarking options for tools that will allow administrators and researchers to meet multiple requirements—including those within NSPM-33—to minimize redundancy for Emory researchers and research teams.
- Below are additional resources for more information on NIH Data Sharing Plans:
Policy Briefs
Policy 7.7 - Financial Conflicts of Interest in Research
Policy 7.8 - Policy on Research Misconduct
Policy 7.12 - Policy for Visiting Scholars & Visiting Students
Policy 7.14 - Investigational Drug Management for Clinical Studies
Policy 7.25 - Controlled Substances & Dangerous Drugs